Cargando…
Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus
Cellular lactate is a key cellular metabolite and marker of anaerobic glycolysis. Cellular lactate uptake, release, production from glucose and glycogen, and interconversion with pyruvate are important determinants of cellular energy. It is known that lactate is present in the spectrum of neoplasms...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570142/ https://www.ncbi.nlm.nih.gov/pubmed/36232656 http://dx.doi.org/10.3390/ijms231911355 |
_version_ | 1784810032893788160 |
---|---|
author | Truszkiewicz, Adrian Bartusik-Aebisher, Dorota Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David |
author_facet | Truszkiewicz, Adrian Bartusik-Aebisher, Dorota Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David |
author_sort | Truszkiewicz, Adrian |
collection | PubMed |
description | Cellular lactate is a key cellular metabolite and marker of anaerobic glycolysis. Cellular lactate uptake, release, production from glucose and glycogen, and interconversion with pyruvate are important determinants of cellular energy. It is known that lactate is present in the spectrum of neoplasms and low malignancy (without necrotic lesions). Also, the appearance of lactate signals is associated with anaerobic glucose, mitochondrial dysfunction, and other inflammatory responses. The aim of this study was the detection of lactate in cell cultures with the use of proton magnetic resonance ((1)H MRS) and a 1.5 Tesla clinical apparatus (MR OPTIMA 360), characterized as a medium-field system. In this study, selected metabolites, together with cellular lactate, were identified with the use of an appropriate protocol and management algorithm. This paper describes the results obtained for cancer cell cultures. This medium-field system has proven the possibility of detecting small molecules, such as lactate, with clinical instruments. (1)H MRS performed using clinical MR apparatus is a useful tool for clinical analysis. |
format | Online Article Text |
id | pubmed-9570142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95701422022-10-17 Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus Truszkiewicz, Adrian Bartusik-Aebisher, Dorota Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David Int J Mol Sci Article Cellular lactate is a key cellular metabolite and marker of anaerobic glycolysis. Cellular lactate uptake, release, production from glucose and glycogen, and interconversion with pyruvate are important determinants of cellular energy. It is known that lactate is present in the spectrum of neoplasms and low malignancy (without necrotic lesions). Also, the appearance of lactate signals is associated with anaerobic glucose, mitochondrial dysfunction, and other inflammatory responses. The aim of this study was the detection of lactate in cell cultures with the use of proton magnetic resonance ((1)H MRS) and a 1.5 Tesla clinical apparatus (MR OPTIMA 360), characterized as a medium-field system. In this study, selected metabolites, together with cellular lactate, were identified with the use of an appropriate protocol and management algorithm. This paper describes the results obtained for cancer cell cultures. This medium-field system has proven the possibility of detecting small molecules, such as lactate, with clinical instruments. (1)H MRS performed using clinical MR apparatus is a useful tool for clinical analysis. MDPI 2022-09-26 /pmc/articles/PMC9570142/ /pubmed/36232656 http://dx.doi.org/10.3390/ijms231911355 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Truszkiewicz, Adrian Bartusik-Aebisher, Dorota Zalejska-Fiolka, Jolanta Kawczyk-Krupka, Aleksandra Aebisher, David Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus |
title | Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus |
title_full | Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus |
title_fullStr | Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus |
title_full_unstemmed | Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus |
title_short | Cellular Lactate Spectroscopy Using 1.5 Tesla Clinical Apparatus |
title_sort | cellular lactate spectroscopy using 1.5 tesla clinical apparatus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570142/ https://www.ncbi.nlm.nih.gov/pubmed/36232656 http://dx.doi.org/10.3390/ijms231911355 |
work_keys_str_mv | AT truszkiewiczadrian cellularlactatespectroscopyusing15teslaclinicalapparatus AT bartusikaebisherdorota cellularlactatespectroscopyusing15teslaclinicalapparatus AT zalejskafiolkajolanta cellularlactatespectroscopyusing15teslaclinicalapparatus AT kawczykkrupkaaleksandra cellularlactatespectroscopyusing15teslaclinicalapparatus AT aebisherdavid cellularlactatespectroscopyusing15teslaclinicalapparatus |